OMER
OMEROS CORP
NASDAQ · Healthcare · Biotechnology · US
$16.35
+0.93%Margins
Gross margin
95.8%
EBITDA margin
346.2%
EBIT margin
-189.5%
Net margin
324.9%
FCF margin
-178.9%
-243.1%
Return on equity
43.5%
Return on assets
-224.6%
Return on invested capital
0.13x
Asset turnover
-$68.7M
Cash from operations
$1.82
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026